Effect of Acetylcholinesterase Inhibitors on Bone Metabolism (NCT06041789)
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism and Fracture Risk Factors Among Older Adults With Mild to Moderate Alzheimer's Disease
🩺 Plain-English Summary (8th-Grade Level)
People with Alzheimer's disease are at an increased risk of bone fracture. Some studies have shown that those taking donepezil have a lower rate of bone fractures, but the reasons for this are unknown. The purpose of this study is to measure the effect of donepezil treatment on bone metabolism factors including bone mineral density, bone turnover markers, and bone quality. Participants in this study will have a bone density test and have blood samples collected at the baseline study visit. Participants will then be randomly assigned to donepezil or matching memantine to be taken daily by mouth for 12 months. Blood samples will be collected at 6 and 12 months. A repeat bone density test will be performed at 12 months. Participants will also complete questionnaires at each study visit.
Who can join: Review the eligibility criteria below.
Location: Duke Memory Disorders Clinic — Durham, North Carolina
Age range: 50 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Duke Memory Disorders Clinic — Durham, North Carolina
📞 Contact the Study Coordinator
Phone: (919) 681-9807
Email: susanne.danus@duke.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Osteoporosis
- Effects of Exoskeleton-Assisted Gait Training on Bone Health and Quality of Life — Englewood, Colorado
- Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis — Toronto, Ontario
- A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis — Basking Ridge, New Jersey
- Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI — West Orange, New Jersey
- Teriparatide (PTH) and Bone Strength in Postmenopausal Women — Toronto, Ontario
- Closing The Post Fracture Care Gap In Manitoba — Winnipeg, Manitoba
Explore by condition: All Osteoporosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.